Clients News • MC Services corporate website
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive




  • EsoCap secures new funding
  • InflaRx to Present at H.C. Wainwright 7th Annual Israel Conference
  • Secarna Pharmaceuticals and Achilles Therapeutics sign research, option and license agreement to develop optimized T cell therapies
  • MagForce AG: MagForce USA, Inc. has Received FDA’s Approval to Proceed with Stage 2B with the Final Protocol of the Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System
  • InflaRx Reports Third Quarter 2021 Financial & Operating Results
  • HepaRegeniX to present key results on MKK4 inhibitors and their therapeutic efficacy at upcoming scientific conferences
  • Imcyse Appoints Gene Mack, MBA as Chief Financial Officer
  • XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development
  • MagForce AG Publishes Financial Results for H1/2021 and Operative Highlights
  • Temedica Appoints Dr Christina Wagner as Chief Financial Officer